Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,760 results for "Product Liability Law & Strategy"...

Mind Your Step: Navigating Landmines in the Joint Defense Landscape
February 28, 2015
In the mass tort litigation context, where one plaintiff typically brings similar claims against numerous defendants within a particular industry, the coordination of defense efforts among codefendants can be a very prudent course of action. This practice, however, is fraught with landmines that can have a devastating effect on clients and practitioners alike.
How to Obtain Social Media Data For Defending Lawsuits
February 28, 2015
Obtaining social media user content under most circumstances is extremely difficult ' unless you use the correct strategy. Simply sending discovery requests without a basic understanding of the information available is a fool's errand. It is pivotal that a practitioner who wants to conduct formal discovery of social media user content understand how each site stores and communicates its data.
Case Notes
February 28, 2015
Discussion of two key cases.
Verdicts
February 28, 2015
A look at recent litigation of interest.
<b><i>Online Extra</b></i>$2.5M Verdict Awarded in First Phila. Risperdal Trial
February 24, 2015
A Philadelphia jury on Feb. 24 awarded $2.5 million to the plaintiff in the first of roughly 1,250 Risperdal mass-tort cases in the city's courts.
To Correct or Not Correct Misinformation in Social Media
January 31, 2015
In June 2014, the FDA issued a draft guidance document, "Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation about Prescription Drugs and Medical Devices." While the draft guidance is not legally binding, it indicates that the FDA will not hold responsible companies that choose to correct (or not correct) third-party misinformation. What are the product liability implications?
Internet Changes Medication Sales Regulations
January 31, 2015
Internet use has changed the way medication purchases are regulated, due in part to patients' free access to information related to pharmaceutical products and medical care. Additionally, the FDA has promoted Internet medication sales by allowing non-print promotion of medications with less detailed information in the ad itself about side effects and precautions than is required of print advertisements.
When Your Data Goes Viral
January 31, 2015
As discussed in Part One of this article, a data breach can jeopardize a company's confidential information such as client records, trade secrets, privileged legal information, or employee records. The discussion concludes herein.
Verdicts
January 31, 2015
Analysis of rulings important to med mal practitioners.
Are Franchisors 'Employers'?
January 31, 2015
Part One of this article analyzed what recent court and NLRB decisions are saying about the franchisor/franchisee employment question. The discussion continues herein.

MOST POPULAR STORIES

  • Private Equity Valuation: A Significant Decision
    Insiders (and others) in the private equity business are accustomed to seeing a good deal of discussion ' academic and trade ' on the question of the appropriate methods of valuing private equity positions and securities which are otherwise illiquid. An interesting recent decision in the Southern District has been brought to our attention. The case is <i>In Re Allied Capital Corp.</i>, CCH Fed. SEC L. Rep. 92411 (US DC, S.D.N.Y., Apr. 25, 2003). Judge Lynch's decision is well written, the Judge reviewing a motion to dismiss by a business development company, Allied Capital, against a strike suit claiming that Allied's method of valuing its portfolio failed adequately to account for i) conditions at the companies themselves and ii) market conditions. The complaint appears to be, as is often the case, slap dash, content to point out that Allied revalued some of its positions, marking them down for a variety of reasons, and the stock price went down - all this, in the view of plaintiff's counsel, amounting to violations of Rule 10b-5.
    Read More ›